San Francisco, California, July 03, 2017: TMR Research announces a new report on the global stem cell assay market. The report examines the historical growth trajectory exhibited by the global stem cell assay market and its latest figures, and further provides reliable forecasts for the stem cell assay market based on complete analysis of the market’s database. The report also takes a close look at the regional and competitive dynamics of the global stem cell assay market in order to shed light on the dynamics of the global market more clearly. The report is titled ‘Stem Cell Assay Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 – 2025.’
Testing antineoplastic drugs in order to check their potency in cancer treatment has emerged as a major application for the global stem cell assay market. The testing covers impurity, toxicity, and other aspects of the tumors and provides a qualitative and quantitative analysis of various aspects of the tumor. The comprehensive figures provided by stem cell assays has driven the demand from the global stem cell assay market.
The growing diversity of applications of stem cell assays is likely to be a major driver for the global stem cell assay market. Pluripotent stem cells have been used in the treatment of several diseases so far and are likely to remain a key part of the healthcare sector in the coming years due to their intrinsic potential to transform into a wide variety of cells in the human body. This makes them a highly promising research avenue in the treatment of diverse conditions such as Alzheimer’s, Parkinson’s, diabetes, rheumatoid arthritis, and retinal diseases, apart from cancer. The growing prevalence of neurological and neurodegenerative conditions, particularly among the growing geriatric demographic in developed countries, is thus likely to be a major driver for the global stem cell assay market.
Steady research and development in the medical sector is likely to remain a key driver for the global stem cell assay market, as the diversity of application of stem cells is purely potential until applied to specific avenues. Growing government support to the medical sector is likely to help the global stem cell assay market in this regard, as significant investment is required to carry out advanced medical research.
Regionally, North America and Europe are likely to remain the leading contributors to the global stem cell assay market due to the presence of a stable healthcare sector in developed countries in the region. The ready incorporation of technological advancements such as stem cell assays in the day to day functioning of the healthcare sector is the key driver for the stem cell assay market in developed countries such as the U.S., Canada, the U.K., Germany, and France.
The report also profiles leading players in the global stem cell assay market in order to shed light on the competitive dynamics of the market. Stem cell assay market leaders examined in the report include Thermo Fisher Scientific Inc., GE Healthcare, STEMCELL Technologies Inc., Bio-Rad Laboratories Inc., Hemogenix Inc., Cell Biolabs Inc., and Promega Corporation.